Adaptation of energy metabolism in breast cancer brain metastases
- PMID: 17308085
- DOI: 10.1158/0008-5472.CAN-06-3137
Adaptation of energy metabolism in breast cancer brain metastases
Abstract
Brain metastases are among the most feared complications in breast cancer, as no therapy exists that prevents or eliminates breast cancer spreading to the brain. New therapeutic strategies depend on specific knowledge of tumor cell properties that allow breast cancer cell growth within the brain tissue. To provide information in this direction, we established a human breast cancer cell model for brain metastasis based on circulating tumor cells from a breast cancer patient and variants of these cells derived from bone or brain lesions in immunodeficient mice. The brain-derived cells showed an increased potential for brain metastasis in vivo and exhibited a unique protein expression profile identified by large-scale proteomic analysis. This protein profile is consistent with either a selection of predisposed cells or bioenergetic adaptation of the tumor cells to the unique energy metabolism of the brain. Increased expression of enzymes involved in glycolysis, tricarboxylic acid cycle, and oxidative phosphorylation pathways suggests that the brain metastatic cells derive energy from glucose oxidation. The cells further showed enhanced activation of the pentose phosphate pathway and the glutathione system, which can minimize production of reactive oxygen species resulting from an enhanced oxidative metabolism. These changes promoted resistance of brain metastatic cells to drugs that affect the cellular redox balance. Importantly, the metabolic alterations are associated with strongly enhanced tumor cell survival and proliferation in the brain microenvironment. Thus, our data support the hypothesis that predisposition or adaptation of the tumor cell energy metabolism is a key element in breast cancer brain metastasis, and raise the possibility of targeting the functional differentiation in breast cancer brain lesions as a novel therapeutic strategy.
Similar articles
-
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.Adv Drug Deliv Rev. 2009 Nov 30;61(14):1250-75. doi: 10.1016/j.addr.2009.05.010. Epub 2009 Aug 27. Adv Drug Deliv Rev. 2009. PMID: 19716393 Review.
-
Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.Cancer Res. 2007 May 1;67(9):4190-8. doi: 10.1158/0008-5472.CAN-06-3316. Cancer Res. 2007. PMID: 17483330
-
Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells.Biotechnol Prog. 2008 Mar-Apr;24(2):334-41. doi: 10.1021/bp070301d. Epub 2008 Feb 29. Biotechnol Prog. 2008. PMID: 18307352
-
Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo.Breast Cancer Res Treat. 2007 Sep;104(3):267-75. doi: 10.1007/s10549-006-9416-4. Epub 2006 Oct 26. Breast Cancer Res Treat. 2007. PMID: 17066321
-
Oxidative metabolism in cancer growth.Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):339-45. doi: 10.1097/01.mco.0000232892.43921.98. Curr Opin Clin Nutr Metab Care. 2006. PMID: 16778561 Review.
Cited by
-
The metabolic adaptation mechanism of metastatic organotropism.Exp Hematol Oncol. 2021 Apr 29;10(1):30. doi: 10.1186/s40164-021-00223-4. Exp Hematol Oncol. 2021. PMID: 33926551 Free PMC article. Review.
-
High Expression of G6PD Increases Doxorubicin Resistance in Triple Negative Breast Cancer Cells by Maintaining GSH Level.Int J Biol Sci. 2022 Jan 1;18(3):1120-1133. doi: 10.7150/ijbs.65555. eCollection 2022. Int J Biol Sci. 2022. PMID: 35173543 Free PMC article.
-
Simultaneous in vivo optical quantification of key metabolic and vascular endpoints reveals tumor metabolic diversity in murine breast tumor models.J Biophotonics. 2019 Apr;12(4):e201800372. doi: 10.1002/jbio.201800372. Epub 2019 Jan 28. J Biophotonics. 2019. PMID: 30565420 Free PMC article.
-
Motif-specific sampling of phosphoproteomes.J Proteome Res. 2008 May;7(5):2140-50. doi: 10.1021/pr800147u. J Proteome Res. 2008. PMID: 18452278 Free PMC article.
-
Metabolic reprogramming in triple-negative breast cancer.Cancer Biol Med. 2020 Feb 15;17(1):44-59. doi: 10.20892/j.issn.2095-3941.2019.0210. Cancer Biol Med. 2020. PMID: 32296576 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical